HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 68/2/370    most recent biolreprod.102.007633v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal My Folders Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Roselli, C. E. Articles by Stormshak, F. Search for Related Content PubMed PubMed Citation Articles by Roselli, C. E. Articles by Stormshak, F. Agricola Articles by Roselli, C. E. Articles by Stormshak, F.

Estrogen Synthesis in Fetal Sheep Brain: Effect of Maternal Treatment with an Aromatase Inhibitor¹

^a Department of Physiology and Pharmacology, Oregon Health & Science University, Portland, Oregon 97201-3098 ^b Department of Animal Sciences, Oregon State University, Corvallis, Oregon 97331-6702

The aim of the present study was to determine whether the fetal lamb brain has the capacity to aromatize androgens to estrogens during the critical period for sexual differentiation. We also determined whether administration of the aromatase-inhibitor 1,4,6-androstatriene-3,17-dione (ATD) could cross the placenta and inhibit aromatase activity (AA) in fetal brain. Eight pregnant ewes were utilized. On Day 50 of pregnancy, four ewes were given ATD-filled Silastic implants, and the other four ewes received sham surgeries. The fetuses were surgically delivered 2 wk later (Day 64 of gestation). High levels of AA (0.8–1.4 pmol/h/mg protein) were present in the hypothalamus and amygdala. Lower levels (0.02–0.1 pmol/h/mg protein) were measured in brain stem regions, cortex, and olfactory bulbs. The Michaelis-Menten dissociation constant (K_m) for aromatase in the fetal sheep brain was 3–4 nM. No significant sex differences in AA were observed in brain. Treatment with ATD produced significant inhibition of AA in most brain areas but did not significantly alter serum profiles of the major sex steroids in maternal and fetal serum. Concentrations of testosterone in serum from the umbilical artery and vein were significantly greater in male than in female fetuses. No other sex differences in serum steroids were observed. These data demonstrate that high levels of AA are found in the fetal sheep hypothalamus and amygdala during the critical period for sexual differentiation. They also demonstrate that AA can be inhibited in the fetal lamb brain by treating the mother with ATD, without harming fetal development.

¹ Supported by NIH grant RR14270 (C.E.R.).

² Correspondence: Charles E. Roselli, Department of Physiology and Pharmacology L334, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97201-3098. FAX: 503 494 4352; rosellic{at}ohsu.edu

This article has been cited by other articles:

				L. M. Gorton, M. M. Mahoney, J. E. Magorien, T. M. Lee, and R. I. Wood Estrogen Receptor Immunoreactivity in Late-Gestation Fetal Lambs Biol Reprod, June 1, 2009; 80(6): 1152 - 1159. [Abstract] [Full Text] [PDF]

				L. M. Jackson, K. M. Timmer, and D. L. Foster Sexual Differentiation of the External Genitalia and the Timing of Puberty in the Presence of an Antiandrogen in Sheep Endocrinology, August 1, 2008; 149(8): 4200 - 4208. [Abstract] [Full Text] [PDF]

				C. E. Roselli, H. Stadelman, R. Reeve, C. V. Bishop, and F. Stormshak The Ovine Sexually Dimorphic Nucleus of the Medial Preoptic Area Is Organized Prenatally by Testosterone Endocrinology, September 1, 2007; 148(9): 4450 - 4457. [Abstract] [Full Text] [PDF]

				J. Robinson Prenatal programming of the female reproductive neuroendocrine system by androgens. Reproduction, October 1, 2006; 132(4): 539 - 547. [Abstract] [Full Text] [PDF]